Skip to content

LSD: all studies

Page 241 of 282: studies 2,401 to 2,410 of 2,815, newest first. Back to the LSD overview

Research

Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report.

Substance Abuse and Rehabilitation 2016 Falk Mancke, Gintarė Kaklauskaitė, Jennifer Kollmer et al.

Nitrous oxide (N2O), a long-standing anesthetic, is known for its recreational use, and its consumption is on the rise. Several case studies have reported neurological and psychiatric complications of N2O use. To date, however, there has not been a study using standardized diagnostic procedures to assess psychiatric comorbidities in a patient consuming N2O. Here, we report about a 35-year-old...

DOI: 10.2147/sar.s114404 (opens in new tab) Full text (opens in new tab) Substance use disorder Addictive disorders Laughing gas Subacute combined degeneration +1

Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.

International review of neurobiology 2016 L F Tófoli, D B De Araujo 25 citations

Despite reports of apparent benefits, social and political pressure beginning in the late 1960s effectively banned scientific inquiry into psychedelic substances. Covert examination of psychedelics persisted through the 1990s; the turn of the century and especially the past 10 years, however, has seen a resurgent interest in psychedelic substances (eg, LSD, ayahuasca, psilocybin). This chapter...

DOI: 10.1016/bs.irn.2016.06.005 (opens in new tab) Full text (opens in new tab) Electroencephalography Neuroimaging Psychedelic agents Substance-related disorders +1

Pharmacology of novel psychoactive substances

edoc (University of Basel) 2016 Anna Rickli 1 citation

This PhD work consists of an in vitro and in vivo part. In the in vivo part, we investigated the role of dopamine in the acute clinical effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in healthy human subjects. The role of dopamine in the addictive effects of drug of abuse is well established, but whether it contributes to the acute psychotropic effects of MDMA is unclear. \nIn...

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).

Neuropharmacology December 1, 2015 Anna Rickli, Dino Luethi, Julian Reinisch et al. 216 citations

N-2-methoxybenzyl-phenethylamines (NBOMe drugs) are newly used psychoactive substances with poorly defined pharmacological properties. The aim of the present study was to characterize the receptor binding profiles of a series of NBOMe drugs compared with their 2,5-dimethoxy-phenethylamine analogs (2C drugs) and lysergic acid diethylamide (LSD) in vitro. We investigated the binding affinities of...

DOI: 10.1016/j.neuropharm.2015.08.034 (opens in new tab) Full text (opens in new tab) Affinity Hallucinogens Novel psychoactive substances Phenethylamines +1

Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.

Journal of Analytical Toxicology October 1, 2015 Kevin G Shanks, Thomas J. Sozio, George S Behonick

Over the last few years, NBOMe substances have been used either as a legal alternative to lysergic acid diethylamide (LSD) or sold surreptitiously as LSD to unknown users. These NBOMe substances have been detected in blotter papers, powders, capsules and liquids. We report the deaths of two teenage male subjects that were related to 25B-NBOMe and 25I-NBOMe in Indiana during 2014. Samples were...

[Psilocybin - public available psychodysleptic].

September 7, 2015 Karolina Dydak, Mariola Śliwińska‐mossoń, Halina Milnerowicz 5 citations

Substances of plant origin have been used to induce hallucinations for a long time, in religious ceremonies and rituals as well as in pain relief. Psilocybin and psilocin naturally occur in the fungal genus Psilocybe. Due to the psychedelic effects and relative harmlessness of these substances and the fact that they do not cause physical addiction, psilocybin and psilocin recently have been...

Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.

Drug and Alcohol Dependence September 3, 2015 Joseph J Palamar, Silvia S Martins, Mark K Su et al.

Background: In recent years, there has been an increase in emergence and use of novel psychoactive substances (NPS) in the US and worldwide. However, there is little published epidemiological survey data estimating the prevalence of use in the US. Method: Data on self-reported NPS use came from the National Survey of Drug Use and Health (2009-2013), a national representative sample of...

DOI: 10.1016/j.drugalcdep.2015.08.028 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders Tryptamines N,N-Dimethyltryptamine +18

Toxicology Rounds

Emergency Medicine News September 1, 2015 Leon Gussow

Figure: Phenethylamine, top left; 2C-I, top right; and 25I-NBOMe, below.FigureAt least 19 young people died between March 2012 and November 2013 from the so-called N-BOMB drugs, synthetic hallucinogens that can be deadlier than LSD, according to the U.S. Drug Enforcement Administration. Chemist Alexander Shulgin developed a series of hallucinogenic 2C drugs in the early 1970s by adding...

Psilocybin, psychological distress, and suicidality

Journal of Psychopharmacology September 1, 2015 Peter S. Hendricks, Matthew W Johnson, Roland R. Griffiths 107 citations

Hendricks et al. (2015) found that having ever used any classic psychedelic substance—namely, dimethyltryptamine (DMT), ayahuasca, lysergic acid diethylamide (LSD), mescaline, peyote or San Pedro, or psilocybin—was associated with a significantly reduced likelihood of past month psychological distress (weighted OR = . 81 (. 72–. 91)), past year suicidal thinking (weighted OR = . 86 (. 78–....

DOI: 10.1177/0269881115598338 (opens in new tab) Full text (opens in new tab) Psilocybin Psychological distress Hallucinogen Clinical psychology +1

Hallucinogens and Dissociatives

ASAM Handbook of Addiction Medicine August 1, 2015 D. Rastegar, Michael I. Fingerhood

Hallucinogens, also referred to as psychedelics, are a broad range of agents that alter perception in different ways. An estimated 1.3 million Americans are current (past month) users of hallucinogens. Hallucinogen use is highest among young adults; 3,4-methylenedioxymethamphetamine (MDMA) is the most commonly used agent, followed by lysergic acid diethylamide (LSD) and phencyclidine (PCP)....